FDA advisors endorse weight-loss drug Qnexa

This is why the news that Vivus is attempting to gain FDA approval for Qnexa again, has many people, in desperate need of an alternative treatment, anxiously awaiting the results. Two years ago Qnexa was rejected by the Food and Drug Administration in23 (Bloomberg) -- Peter Tam, president of Vivus Inc., talks about the outlook for the company's Qnexa obesity drug after US Food and Drug Administration advisers voted 20-2 yesterday that the pill's benefits outweigh its risks.An FDA

Read more ...